SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Follow-up) — Frida Kahlo

PatientFrida Kahlo
Date of birth1989-07-06
IdentifiersMRN HR-NI011-SYN; SSN (made up) 000-11-4390
Document date2026-10-15
AuthorMarisol Ortega, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Four-week chronic pain follow-up and first opioid dose reduction. [S]

History of Present Illness

Ms. Kahlo returns four weeks after her first visit. The cold she had last week has cleared. She has gone to physical therapy twice a week, missing one aquatic session while she was ill, and wears the new shoe lift. On duloxetine 60 mg for two weeks she has had no nausea, sweating, or dizziness. The burning in her right leg is less, and she now stands at the easel for about 20 minutes. She has kept to no more than four oxycodone tablets a day and on most days takes three or four. She is ready for the first dose reduction she agreed to two weeks ago, and she starts weekly cognitive behavioral therapy for chronic pain today. [S]

ElementDetail
Recent illnessCommon cold last week, cleared
RehabilitationPhysical therapy twice weekly; one session missed while ill; shoe lift in use
Duloxetine 60 mgTwo weeks, no side effects
FunctionStands at the easel for about 20 minutes
Opioid useThree or four oxycodone tablets on most days; never more than four
TaperReady for the agreed first reduction

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever or drowsiness
RespiratoryNegativeCough gone
GastrointestinalNegativeNo nausea or constipation
MusculoskeletalPositiveBack and pelvic pain, easing; right ankle pain on standing; no falls
NeurologicalPositiveLess burning in the right leg; no new weakness; no bladder or bowel control change
PsychiatricNegativeMood better; PHQ-9 score 6 with item 9 scored 0

6 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Oxycodone 10 mg oral tablet, one tablet every 6 hours as needed for pain, no more than four a day (60 MME a day)One tablet by mouth every 6 hours as needed for pain; no more than 4 tablets a dayOral route2024-03-04 to 2026-10-15completedS
Oxycodone 10 mg oral tablet, one tablet three times daily as needed for painOne tablet by mouth three times daily as needed for painOral route2026-10-15activeS
Oxycodone 5 mg oral tablet, one tablet at bedtime as needed for painOne tablet by mouth at bedtime as needed for painOral route2026-10-15activeS
Duloxetine 30 mg delayed-release oral capsule, one capsule dailyOne capsule by mouth dailyOral route2026-09-17 to 2026-10-01completedS
Duloxetine 60 mg delayed-release oral capsule, one capsule dailyOne capsule by mouth dailyOral route2026-10-01activeS
Acetaminophen 500 mg oral tablet, two tablets three times dailyTwo tablets by mouth three times daily; no more than 3,000 mg a dayOral route2026-09-17activeS
Diclofenac sodium 1% topical gel, 2 g to the right ankle four times dailyApply 2 g to the right ankle and foot four times dailyTopical route2026-09-17activeS
Cholecalciferol (vitamin D3) 2,000 units oral tablet, one tablet dailyOne tablet by mouth dailyOral route2026-09-17activeS
Naloxone 4 mg nasal spray, one spray into one nostril for suspected opioid overdose; may repeat in the other nostrilFor suspected opioid overdose: one spray into one nostril and call 911; if there is no response after 2 to 3 minutes, give a second spray in the other nostrilNasal route2026-09-17activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-10-15Body height160cmS
2026-10-15Body weight50.5kgS
2026-10-15Body mass index (BMI) [Ratio]19.7kg/m2S
2026-10-15Systolic blood pressure114mm[Hg]S
2026-10-15Diastolic blood pressure72mm[Hg]S
2026-10-15Heart rate78/minS
2026-10-15Respiratory rate14/minS
2026-10-15Body temperature36.7CelS
2026-10-15Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-10-15Mean score [PEG]6{score}S
2026-10-15Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S

Physical Exam

Vital signs recorded on 2026-10-15; see the Vital Signs section. [S]

SystemFinding
GeneralAlert and not sedated; pupils equal and normal in size
LungsClear
BackLumbar paraspinal tenderness, unchanged
Right ankleBony enlargement and reduced motion; no effusion
GaitSteadier with the cane and shoe lift

Problems

ProblemClinical statusVerificationCodeProvenance
Chronic low back and pelvic pain after remote spinal and pelvic fractures and spinal surgery, with neuropathic features in the right leg; linked to the documented 1925 injuriesactiveconfirmed G89.21S — Synthetic modern diagnosis linked to the documented injuries; the neuropathic interpretation is R.
Post-traumatic osteoarthritis of the right ankle and foot after multiple leg fractures and a foot dislocationactiveconfirmed M19.171S — Synthetic diagnosis confirmed on the synthetic ankle X-ray.
Right leg weakness, atrophy, and shortening after childhood poliomyelitis; a congenital spinal anomaly has been proposed retrospectivelyactiveprovisional B91S — Synthetic modern coding of the documented childhood diagnosis; the alternative remains R.
Long-term opioid therapy for chronic pain, 60 MME a day at intakeactiveconfirmed Z79.891S — Synthetic modern medication status; not a historical assertion.
Vitamin D deficiencyactiveconfirmed E55.9S — Synthetic finding from the baseline 25-hydroxyvitamin D.
Acute viral upper respiratory infection (common cold), resolved without antibioticsresolvedconfirmed J06.9S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyPEG pain, enjoyment of life, and general activity scoreEvery visitCompleted today6.0, down from 7.3 at intake
SurveyPHQ-9 depression score, with item 9Every 2 to 4 weeks during active treatmentCompleted today6, down from 8, with item 9 scored 0
Medication safetyOpioid benefits and harms: function, sedation, constipation, fallsEvery visit during a taper; at least every 3 monthsCompleted todayFunction improving; no sedation, constipation, or falls
Medication safetyTaper stepAbout 10 percent a month for long-term therapy, adjusted to her responseCompleted today60 to 52.5 MME a day, a 12.5 percent step, the smallest change possible with whole 5 mg tablets; agreed with her
Medication safetyOpioid withdrawal symptomsAt each contact after a reductionDueFirst check at next week's visit
Medication safetyOpioid use disorder assessmentBefore tapering and whenever concerns ariseCompleted todayNo signs: one prescriber, a consistent urine drug test, no early refills or dose escalation
Medication safetyPrescription drug monitoring program checkBefore each opioid prescription; at least every 3 monthsCompleted todayChecked before today's new prescription: a single prescriber and no sedatives
LaboratoryUrine drug test, with consentBefore long-term therapy, then at least annuallyUp to dateAt intake, consistent with the prescribed oxycodone only
Medication safetyNaloxone at home, with a family member trainedOffer when starting or continuing opioids; review each visitUp to dateConfirmed at home and in date last week; reviewed again today
Medication safetyConcurrent benzodiazepines or other sedativesEvery visitCompleted todayNone
Medication safetyDuloxetine tolerance after a dose changeAbout 2 weeks after each dose changeCompleted todayNo side effects on 60 mg; blood pressure 114/72
LaboratoryALT on regular acetaminophenPeriodically when acetaminophen approaches 3 g a dayUp to date22 U/L at intake; recheck at the six-week review
ExaminationRight ankle examination: range of motion, effusion, alignmentEvery visitCompleted todayUnchanged; no effusion
ImagingRight ankle radiographOnly for diagnostic uncertainty, clinical change, or surgical planningNot indicatedNo clinical change
ReferralCognitive behavioral therapy for chronic painWeeklyUp to dateWeekly sessions start today
Self-managementExercise program adherenceEvery visitCompleted todayPhysical therapy twice weekly, one session missed while ill; home exercises daily
Laboratory25-hydroxyvitamin DAbout 3 months after starting repletionDueRecheck in about nine weeks
Medication safetyInfluenza vaccineEvery seasonCompleted todayGiven today

Goal progress:

Immunizations given today: Influenza vaccine, 2026-2027 season [S]

Guideline basis: CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022); Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians (2017); VA/DoD Clinical Practice Guideline for the Diagnosis and Treatment of Low Back Pain (2022); CMID: Clinical Monitoring Intelligence Database, osteoarthritis and depression monographs (2026)

Follow-up: Adult preventive visit next week, with a check for withdrawal. Six-week chronic pain review in two weeks. Next scheduled visit 2026-10-22: adult preventive visit. [S]